This Course at MIT pages provide context for how the course materials published on OCW were used at MIT. They are part of the OCW Educator initiative, which seeks to enhance the value of OCW for educators.
This page focuses on the course 20.201 Mechanisms of Drug Actions as it was taught by Prof. Peter Dedon, Prof. Steven Tannenbaum, Dr. Mark Murcko, and Dr. Charles Knutson in Fall 2013.
This course addresses the scientific basis for the development of new drugs. The course is team-taught by four MIT instructors, and includes guest lectures by scientists in the pharmaceutical industry.
Topics covered in the course include mechanisms of action of drugs and drug classes, role of drug structure and drug transport proteins in uptake and distribution, kinetics of drug behavior in the human body, metabolism, drug interactions leading to toxicity, drug-receptor interactions, and the role of pharmacogenetics in drug actions.
What do students get out of 20.201?
Students will gain preparedness for graduate work in biological engineering or industry related jobs.
Permission of the instructor
It is a “Restricted Elective,” which means that it intended to prepare students for advanced graduate work. Undergraduate students in biological engineering are required to take two restricted electives.
Every fall semester
The students' grades were based on the following activities:
A combination of advanced undergraduate (juniors and seniors) and graduate students studying biological engineering.
There are no formal prerequisites, but students should have knowledge of biochemistry and organic chemistry.
During an average week, students were expected to spend 12 hours on the course, roughly divided as follows: